Clin2
NCT06760065Possibly a fitNot yet recruiting

Comparing two treatments for H. pylori after failed first therapy

Helicobacter Pylori Infection Helicobacter Pylori Eradication Patient Education

Part of Digestive system, Infections clinical trials.

This trial tests a new dual therapy (Keverprazan Hydrochloride plus amoxicillin) against a standard quadruple therapy guided by antibiotic sensitivity. It is for people whose H. pylori infection has not been cured by at least one prior treatment.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
316 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are between 18 and 75 years old.
  • You have had at least one previous H. pylori treatment that did not work.
  • You currently have an active H. pylori infection (confirmed by a breath test or culture).
  • You are not pregnant, breastfeeding, or planning to become pregnant during the study.
  • You have not used certain antibiotics or stomach acid medications recently (within 30 days for some, 14 days for others).
  • You do not have serious health conditions like active bleeding ulcers, stomach cancer, or certain allergies.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06734260Recruiting· Phase 3
Optimizing a two-drug therapy for H. pylori infection

This trial tests a two-drug combination (keverprazan and amoxicillin) to see if it works better for treating H. pylori, a bacteria that can cause stomach problems. It is for people who have had H. pylori before and need treatment again.

Guangzhou, Guangdong
NCT07122024Recruiting· Phase 4
Testing a dual therapy for H. pylori treatment

This trial tests a two-drug treatment (keverprazan and amoxicillin) for people who have H. pylori and have not been treated for it before. The goal is to see if this newer combination works well and is safe.

Hangzhou, Zhejiang
NCT07750938Not yet recruiting· Phase 4
Optimized treatment for H. pylori infection with stronger acid control

This study tests a new combination of medicines to treat H. pylori, a common stomach infection that can cause ulcers. The goal is to see if a stronger acid-reducing approach helps the treatment work better.

NCT07115173Not yet recruiting· Phase 4
Triple therapy study for H. pylori infection

This study tests a triple therapy drug combination to treat Helicobacter pylori (H. pylori), a bacteria that can cause stomach problems. It may help people with certain stomach conditions who need to get rid of the infection.

NCT06349486Recruiting
Comparing new treatments for H. pylori infection

This trial compares three different medication combinations to see which works best for treating H. pylori infection. If you have H. pylori and haven't been treated yet, you may be able to join.

Kaohsiung City
NCT06777732Not yet recruiting· Early Phase 1
Keverprazan for H. pylori infection: a new treatment option

This trial tests a new medication called Keverprazan to see if it can safely and effectively clear an H. pylori infection in the stomach. It is for people who have not yet been treated for this infection.

Hear when a new Helicobacter Pylori Infection Helicobacter Pylori Eradication Patient Education trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.